SEC Form 4 · accession 0001209191-15-004175
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Kauffman
Officer — Chief Executive Officer · Director
Period of report
Jan 12, 2015
Accepted (ET)
Jan 14, 2015 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2014 | G | 20,000 | $0.00 | D | 788,963 | I | By Spouse |
| Common Stock | Jan 12, 2015 | S | 25,000 | $33.00 | D | 562,596 | D | |
| Common Stock | Jan 12, 2015 | S | 25,000 | $33.00 | D | 763,963 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported on this Form 4 was effected as part of an underwritten public offering of common stock of Karyopharm Therapeutics Inc. with the Reporting Person as a selling stockholder in the offering.
- F2The sale reported on this Form 4 was effected as part of an underwritten public offering of common stock of Karyopharm Therapeutics Inc. with the spouse of the Reporting Person as a selling stockholder in the offering.